Multiple Myeloma Clinical Trials in Barcelona

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2022-03-21
Mar 21, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Southington, Connecticut
  • +63 more
2022-03-24
Mar 24, 2022
J
Recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +113 more
2022-03-24
Mar 24, 2022
G
Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +35 more
2022-03-17
Mar 17, 2022
G
Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
2022-02-25
Feb 25, 2022
O
Terminated
  • Multiple Myeloma
  • Melphalan flufenamide (Melflufen)
  • +3 more
  • Boston, Massachusetts
  • +15 more
2022-03-04
Mar 4, 2022
O
Terminated
  • Relapse Multiple Myeloma
  • Multiple Myeloma
  • Melphalan Flufenamide
  • +2 more
  • Plovdiv, Bulgaria
  • +25 more
2022-02-16
Feb 16, 2022